Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c735 |
|---|---|
| Identifier | NCT06127043 |
| Trial Title | A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Rosnilimab|DRUG: Placebo |
Participant Information
| Sponsor | AnaptysBio, Inc. |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-12-04 |
|---|---|
| Primary Completion Date | 2026-01 |
| Completion Date | 2026-05 |